Good News: Mild COVID-19 Induces Lasting Antibody Protection

According to a recent study from Washington University, people who have had mild illness develop antibody-producing cells that can last a lifetime.

Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.

The findings, published May 24 in the journal Nature, suggest that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.

Read more of the original article from WorldHealth

Kyolic Immune Formula 103
SHARE